Skip to content

Standard treatment group:Standard treatment

11 trials

Sponsors

Chinese People's Liberation Army General Hospital, Beijing Hospital, Beijing Tsinghua Changgung Hospital, Affiliated Hospital of Guilin Medical College, The Second Affiliated Hospital of the Army Medical University

Conditions

Acute Coronary Syndromes with Type 2 DiabetesAcute ischemic strokeAcute ischemic stroke (AIS) accounts for about 60-70% of all strokes, consisting of the major disease burden of stroke.Acute-on-chronic liver failure (ACLF) complicated with infection-associated thrombocytopeniaGastrointestinal dysfunction after esophageal cancer surgeryGlioblastomaLschemic strokeMetastatic prostate cancer

Early Phase 1

Phase 4

A clinical study on drug reduction and withdrawal initiated by investigators in the treatment of SLE patients with belyumumab for injection
RecruitingChiCTR2100052342
Affiliated Hospital of Guilin Medical Collegesystemic lupus erythematosus
Start: 2021-12-01Updated: 2022-10-17
Efficacy and safety of intra-arterial thrombolysis in acute ischemic stroke patients without large or medium vessel occlusion stroke a multi-center, prospective, randomized, blind-endpoint trial
Active, not recruitingChiCTR2400081660
The Second Affiliated Hospital of the Army Medical UniversityAcute ischemic stroke
Start: 2024-03-07Updated: 2024-03-11
Intravascular therapy combinated with agatroban for acute ischemic stroke: a multicenter, double-blind clinical trial
Active, not recruitingChiCTR2500095382
Second Affiliated Hospital of Army Medical University, PLALschemic stroke
Start: 2025-01-08Updated: 2025-01-13
Efficacy and Safety of PCSK9 Inhibitors in Patients with Acute Ischemic Stroke Undergoing Endovascular Therapy: A Prospective, Multicenter, Open-Label, Parallel, Randomized Controlled Clinical Trial
Active, not recruitingChiCTR2500104176
Southern Medical University Southern HospitalAcute ischemic stroke (AIS) accounts for about 60-70% of all strokes, consisting of the major disease burden of stroke.
Start: 2026-01-01Updated: 2025-06-16
A Prospective, Multicenter Clinical Study of Recombinant Human Thrombopoietin (rhTPO) in the Treatment of Thrombocytopenia Complicated with Infection in Patients with Acute-on-Chronic Liver Failure (ACLF)
Active, not recruitingChiCTR2600130254
Shandong Public Health Clinical CenterAcute-on-chronic liver failure (ACLF) complicated with infection-associated thrombocytopenia
Start: 2026-08-20Updated: 2026-08-24

Unknown Phase

Related Papers